- Presentations
- Documents
- Infographics
Viral hepatitis 2014
Mario Mondelli
•
9 years ago
Market Approaches for Innovation and Access
UNITAID
•
12 years ago
Gilead Sciences' Novel Antiviral Drugs Morgan Stanley Report 1993
StreetReports
•
9 years ago
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997
MountainHarborGmbH
•
9 years ago
"State of the Gilead" presentation by Dr. Michael L. Riordan, the founder and CEO of Gilead Sciences, in July 1992
presentationselect
•
10 years ago
Dr. Michael Riordan's "on board" discussion with each new Gilead
McGregorEssays
•
10 years ago
Gilead Sciences Stock Offering Prospectus 1996-- Excerpts
Boardnotes
•
10 years ago
Gilead Sciences Name Filed by Company Founder Michael L Riordan
calstatehistories
•
10 years ago
The Path to Public Office: Medicine versus Law, by Michael L. Riordan
Perspectivestoday
•
10 years ago
Gilead Sciences Initial Public Offering Prospectus January 1992
LucasBillings
•
9 years ago